NIANSEN LIU: Open Payments
NPI 1679578371 · CLEVELAND, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,830 in 87 payments from 14 companies in 2025. Trend: 2023 $2,065 · 2024 $1,685 · 2025 $1,830
Food & beverage: $1,830
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 15 | $324 |
| Alkermes, Inc. | 13 | $303 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $209 |
| Teva Pharmaceuticals USA, Inc. | 10 | $196 |
| ABBVIE INC. | 10 | $158 |
| Vanda Pharmaceuticals Inc. | 8 | $143 |
| Neurocrine BioSciences, Inc. | 5 | $132 |
| Axsome Therapeutics, Inc. | 3 | $76 |
| Lundbeck LLC | 3 | $74 |
| Janssen Pharmaceuticals, Inc | 3 | $67 |
Products named: REXULTI, LYBALVI, CAPLYTA, AUSTEDO XR, VRAYLAR, FANAPT, INGREZZA, SPRAVATO.
Industry payments across TN — which companies pay providers there.
